The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-((S)-1-fluoro-6-guanidino-2-oxohexan-3-yl)-1-((S)-2-(4-isopropylbenzamido)-3-methylbutanoyl)pyrrolidine-2-carboxamide ID: ALA4557368
PubChem CID: 126678437
Max Phase: Preclinical
Molecular Formula: C27H41FN6O4
Molecular Weight: 532.66
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)c1ccc(C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)CF)C(C)C)cc1
Standard InChI: InChI=1S/C27H41FN6O4/c1-16(2)18-9-11-19(12-10-18)24(36)33-23(17(3)4)26(38)34-14-6-8-21(34)25(37)32-20(22(35)15-28)7-5-13-31-27(29)30/h9-12,16-17,20-21,23H,5-8,13-15H2,1-4H3,(H,32,37)(H,33,36)(H4,29,30,31)/t20-,21-,23-/m0/s1
Standard InChI Key: ZIKHVSLQIYKTKY-FUDKSRODSA-N
Molfile:
RDKit 2D
38 39 0 0 0 0 0 0 0 0999 V2000
22.9020 -11.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6205 -10.6004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2818 -10.1266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0358 -9.3484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2196 -9.3419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9613 -10.1161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9755 -11.3579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.9831 -10.5427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7860 -13.0146 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7784 -13.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0654 -14.2282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.6966 -10.1401 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3979 -10.5562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1074 -10.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3904 -11.3714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0922 -11.7834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0847 -12.5985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1149 -9.3380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8118 -10.5674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5227 -10.1645 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.4813 -14.2465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6160 -11.4159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3214 -11.8284 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.2006 -11.4081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4907 -11.8128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4861 -12.6300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8955 -12.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1845 -13.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5999 -13.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7852 -11.4003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7930 -10.5829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0884 -10.1705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3774 -10.5753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3755 -11.3967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0807 -11.8054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6714 -10.1637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6749 -9.3465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9620 -10.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 2 1 0
8 12 1 0
14 18 2 0
3 8 1 1
8 7 2 0
9 10 1 0
10 11 2 0
12 13 1 0
13 14 1 0
13 15 1 6
15 16 1 0
16 17 1 0
17 9 1 0
14 19 1 0
19 20 1 0
10 21 1 0
2 22 1 0
22 1 1 0
22 23 2 0
1 24 1 0
24 25 1 0
25 26 2 0
1 27 1 6
27 28 1 0
27 29 1 0
25 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
33 36 1 0
36 37 1 0
36 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 532.66Molecular Weight (Monoisotopic): 532.3173AlogP: 1.84#Rotatable Bonds: 13Polar Surface Area: 157.48Molecular Species: BASEHBA: 5HBD: 5#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.63CX Basic pKa: 11.91CX LogP: 1.60CX LogD: -0.49Aromatic Rings: 1Heavy Atoms: 38QED Weighted: 0.15Np Likeness Score: -0.34
References 1. Hatcher JM, Du G, Fontán L, Us I, Qiao Q, Chennamadhavuni S, Shao J, Wu H, Melnick A, Gray NS, Scott DA.. (2019) Peptide-based covalent inhibitors of MALT1 paracaspase., 29 (11): [PMID:30954428 ] [10.1016/j.bmcl.2019.03.046 ]